Hepion Pharmaceuticals Stock Forecast

Sell candidate since Jul 01, 2026

The Hepion Pharmaceuticals, Inc. stock price fell by -11.57% on the last day (Wednesday, 1st Jul 2026) from $0.0679 to $0.0600. During the last trading day the stock fluctuated 16.67% from a day low at $0.0600 to a day high of $0.0700. The price has fallen in 6 of the last 10 days but is still up by 16.5% over the past 2 weeks. Volume has increased on the last day by 10 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 10 thousand shares were bought and sold for approximately $602.28 .

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.0527 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 21.42% during the next 3 months and, with a 90% probability hold a price between $0.0639 and $0.124 at the end of this 3-month period.

HEPA Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 17, 2026, and so far it has risen 20.00%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Hepion Pharmaceuticals, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.0666. On a fall, the stock will find some support from the short-term average at $0.0600. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Hepion Pharmaceuticals, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Hepion Pharmaceuticals, Inc. stock

Hepion Pharmaceuticals, Inc. finds support from accumulated volume at $0.0570 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0100 between high and low, or 16.67%. For the last week, the stock has had daily average volatility of 18.59%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HEPA) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Hepion Pharmaceuticals, Inc. to open at $0.0633, and during the day (based on 14 day Average True Range), to move between $0.0546 and $0.0654, which gives a possible trading interval of +/-$0.0108 (+/-19.76%) up or down from last closing price. If Hepion Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 19.76% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0605 (0.83%) than the support at $0.0570 (5.00%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Hepion Pharmaceuticals, Inc. stock A Buy?

Hepion Pharmaceuticals, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -2.225 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 2, 2026 - $0.0633 ( 5.56%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk